Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial. (2023)

First Author: Turkova A

Attributed to: Blood borne viruses funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2352-4642(23)00164-5

PubMed Identifier: 37562418

Publication URI: http://europepmc.org/abstract/MED/37562418

Type: Journal Article/Review

Volume: 7

Parent Publication: The Lancet. Child & adolescent health

Issue: 10

ISSN: 2352-4642